Clinical Trial Update: Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) [Phase 3]

View source ↗

Summary

This report notes the termination of a Phase 3 trial evaluating the combination of Alendronate and Leuprolide (Lupron) for osteoporosis in patients with cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• FOSAMAX (ALENDRONATE SODIUM)
• Lupron (leuprolide)

Snippet

Sponsor: Canadian Urology Research Consortium | Conditions: Osteoporosis | Phase 3 | Status: TERMINATED